Lucid Diagnostics Inc.
LUCD
$1.20
-$0.01-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.55% | 21.05% | 18.01% | 21.81% | 6.24% |
| Total Depreciation and Amortization | -53.30% | -36.66% | -19.12% | -5.39% | 29.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.15% | -69.89% | -53.94% | -62.08% | -25.37% |
| Change in Net Operating Assets | -178.08% | -146.69% | -132.72% | -103.92% | -36.28% |
| Cash from Operations | -34.50% | -63.30% | -73.77% | -23.46% | -10.55% |
| Capital Expenditure | -33.94% | 14.86% | 59.35% | 68.98% | 75.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -192.31% | -125.70% | 85.48% | 93.94% | 94.62% |
| Total Debt Issued | 116.15% | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -45.99% | -46.05% | -74.55% | -78.82% | -68.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 59.99% | 155.40% | 155.40% | 70.02% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.77% | 44.10% | 35.71% | -10.57% | 1,028.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.76% | -231.52% | -6,918.35% | -75.69% | 88.53% |